Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor

被引：9
|
作者：
Robert, Lucie [1 ,2 ]
Langner-Lemercier, Sophie [3 ]
Angibaud, Alexis [1 ]
Sale, Alexandre [1 ]
Thepault, Fanny [4 ]
Corre, Romain [1 ,5 ]
Lena, Herve [1 ,5 ]
Ricordel, Charles [1 ,5 ]
机构：
[1] CHU Rennes, Resp Med Dept, Rennes, France
[2] CLCC Eugene Marquis, Serv Oncol Med, Rennes, France
[3] CHU Rennes, Neurol Dept, Rennes, France
[4] CH St Malo, Resp Med Dept, St Malo, France
[5] CLCC Eugene Marquis, Chem Oncogenesis Stress & Signaling, INSERM, U1242, Rennes, France
来源：
CLINICAL LUNG CANCER | 2020年 / 21卷 / 05期
关键词：
Atezolizumab; Immune encephalitis; Immune-related adverse events; NSCLC; Nivolumab; NEUROLOGICAL TOXICITIES; IPILIMUMAB; MELANOMA;
D O I：
10.1016/j.cllc.2020.03.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E474 / E477
页数：4
相关论文
共 50 条
  • [1] Immune-related encephalitis after immune checkpoint inhibitor therapy
    Buckley, Monica W.
    Balaji Warner, Aanika
    Brahmer, Julie
    Cappelli, Laura C.
    Sharfman, William H.
    Fuchs, Ephraim
    Kang, Hyunseok
    Forde, Patrick M.
    Gladstone, Douglas E.
    Ambinder, Richard
    Kelly, Ronan J.
    Lipson, Evan J.
    Gojo, Ivana
    Lee, Edward J.
    Johnson, Tory P.
    Saidha, Shiv
    Llinas, Rafael
    Ostrow, Lyle W.
    Naidoo, Jarushka
    Probasco, John C.
    ONCOLOGIST, 2024, 30 (01)
  • [2] Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors
    Fiala, Ondrej
    Sorejs, Ondrej
    Sustr, Jan
    Kucera, Radek
    Topolcan, Ondrej
    Finek, Jindrich
    ANTICANCER RESEARCH, 2020, 40 (03) : 1219 - 1227
  • [3] Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational Study
    Masaki, Kou
    Miyazaki, Motoyasu
    Kakimoto, Hideki
    Fukiage, Yuma
    Fukue, Haruka
    Nakashima, Akio
    Imakyure, Osamu
    Sparreboom, Alex
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [4] The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors
    Fukushima, Taito
    Kobayashi, Satoshi
    Ueno, Makoto
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (09) : 949 - 958
  • [5] Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
    Dolladille, Charles
    Ederhy, Stephane
    Sassier, Marion
    Cautela, Jennifer
    Thuny, Franck
    Cohen, Ariel A.
    Fedrizzi, Sophie
    Chretien, Basile
    Da-Silva, Angelique
    Plane, Anne-Flore
    Legallois, Damien
    Milliez, Paul U.
    Lelong-Boulouard, Veronique
    Alexandre, Joachim
    JAMA ONCOLOGY, 2020, 6 (06) : 865 - 871
  • [6] Immune-related musculoskeletal toxicities among cancer patients treated with immune checkpoint inhibitors: a systematic review
    Abdel-Rahman, Omar
    Eltobgy, Mostafa
    Oweira, Hani
    Giryes, Anwar
    Tekbas, Aysun
    Decker, Michael
    IMMUNOTHERAPY, 2017, 9 (14) : 1175 - 1183
  • [7] Immune-related Bell's palsy in melanoma patients treated with immune checkpoint inhibitors
    Beninato, Teresa
    Fuca, Giovanni
    Di Guardo, Lorenza
    Vetrano, Irene
    Valeri, Barbara
    Nesa, Francesco
    Del Vecchio, Michele
    Cimminiello, Carolina
    MELANOMA RESEARCH, 2021, 31 (02) : 178 - 180
  • [8] Immune-related adverse events in cancer patients being treated with immune checkpoint inhibitors
    Byrne, Margaret M.
    Lucas, Mathew
    Pai, Lori
    Breeze, Janis
    Parsons, Susan K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (06) : 650 - 657
  • [9] T-Cell Subtypes and Immune Signatures in Cutaneous Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
    Absmaier-Kijak, Magdalena
    Iuliano, Caterina
    Kaesler, Susanne
    Biedermann, Tilo
    Posch, Christian
    Brockow, Knut
    CANCERS, 2024, 16 (06)
  • [10] Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Veiga, F.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    PULMONOLOGY, 2024, 30 (04): : 352 - 361
12345